Chatbot Implementation In The Clinical Informed Consent Process

Part of paid clinical trials in Houston, Texas.

Sponsor
M.D. Anderson Cancer Center
Study ID
NCT07756515
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Informed Consent

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • CoCo Chatbot — OTHER
    A patient-facing chatbot designed to obtain informed consent

Study Details

The purpose of this study is to determine the feasibility of implementing the chatbot "CoCo" in the IC process for research studies. We hypothesize that implementing a chatbot into the IC process will facilitate accurate information delivery and enhance participant comprehension and process satisfaction compared to traditional remote consent methods.

Key Dates

First listed
Aug 10, 2026
Start date
Jan 1, 2027
Status verified
Aug 2026
Primary completion
Dec 17, 2028
Completion
Dec 17, 2031

Study Design

Enrollment
100 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Experimental: Phase I Feasibility Cohort: Remote IC Process for Non-Therapeutic Studies
    All participants will be provided with an abbreviated informed consent form describing this study and providing sufficient information for patients to make an informed decision regarding participation.

Primary Outcome Measure

Safety and Adverse Events (AEs) [ Time Frame: Through study completion; an average of 1 year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
UT MD AndersonHoustonTexas77030
Funda Meric-Bernstam, MD
713-794-1226
Funda Meric-Bernstam, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Houston, TX

Related Studies